Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Other 1Lymphoid 1

Conditions

Motor Activity 3Breast Neoplasms 3Pancreatic Neoplasms 2Multiple Myeloma 2Colorectal Neoplasms 2Smoldering Multiple Myeloma 1Skin Neoplasms 1Sarcopenia 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Obesity 1Neoplasms 1Melanoma 1Lymphedema 1Lung Neoplasms 1Colonic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Brain Neoplasms 1

Interventions

Cyclophosphamide 56fludarabine 30Methotrexate 24blinatumomab 23Dexamethasone 21Cytarabine 21Vincristine 19venetoclax 18Specimen Handling 16fludarabine phosphate 15Whole-Body Irradiation 13Stem Cell Transplantation 12Biopsy 12Tacrolimus 10Mycophenolic Acid 10Immunotherapy, Adoptive 10Daunorubicin 10Thiotepa 9Rituximab 9Prednisone 9Mercaptopurine 9Melphalan 9Magnetic Resonance Spectroscopy 8Doxorubicin 8pegaspargase 7Granulocyte Colony-Stimulating Factor 7Cyclosporine 7olverembatinib 6Mesna 6Inotuzumab Ozogamicin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Resistance Training × Clear all
NCT07228741 2026-04-24

Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity

St. Jude Children's Research Hospital

Phase 2 Recruiting
20 enrolled
LymphoidOtherOther hematologic neoplasm

Obesity, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡